Meds Apotek AB (STO:MEDS)
23.10
+0.10 (0.43%)
Nov 2, 2026, 5:24 PM CET
Meds Apotek AB Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Meds Apotek AB stock has a consensus rating of "Strong Buy" and an average price target of kr 43.00. The average 1-year stock price forecast is 86.15% higher than the current stock price, while the lowest is kr 34.00 (+47.19%) and the highest is kr 52.00 (+125.11%).
Price Target: kr 43.00 (+86.15%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Meds Apotek AB stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
1.12B
from 1.01B
Increased by 11.24%
Revenue Next Year
1.31B
from 1.12B
Increased by 16.66%
EPS This Year
1.16
from 0.84
Increased by 38.54%
EPS Next Year
2.13
from 1.16
Increased by 83.62%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.